| Avvisati G
Bortezomib plus melphalan and prednisone for multiple myeloma. [Comment, Letter]
N Engl J Med 2008 Dec 11; 359(24):2613; author reply 2613-4.
Full Citation | Find Related Articles |
| Tsubokura M, Kami M, Komatsu T
Bortezomib plus melphalan and prednisone for multiple myeloma. [Comment, Letter]
N Engl J Med 2008 Dec 11; 359(24):2613; author reply 2613-4.
Full Citation | Find Related Articles |
| Islam A, Ambrus JL
Bortezomib plus melphalan and prednisone for multiple myeloma. [Comment, Comparative Study, Letter]
N Engl J Med 2008 Dec 11; 359(24):2613; author reply 2613-4.
Full Citation | Find Related Articles |
| Richter B, Bandeira-Echtler E, Bergerhoff K, et al.
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes. [Journal Article]
Vasc Health Risk Manag 2008; 4(4):753-68.
Abstract | Full Citation |
| Green J, Feinglos M
New combination treatments in the management of diabetes: focus on sitagliptin-metformin. [Journal Article]
Vasc Health Risk Manag 2008; 4(4):743-51.
Abstract | Full Citation |
| Kanagaraj A, Marthandam LR, Sriramakrishnan V, et al.
Tuberculous liver abscess. [Letter]
J Assoc Physicians India 2008 Aug.:647-8.
Full Citation |
| Kao DP
What can we learn from drug marketing efficiency? [Journal Article, Research Support, N.I.H., Extramural]
BMJ 2008.:a2591.
Full Citation | Publisher Full Text | Find Related Articles |
| Ratjen F, Bush A
Amiloride: still a viable treatment option in cystic fibrosis? [Comment, Editorial]
Am J Respir Crit Care Med 2008 Dec 15; 178(12):1191-2.
Full Citation | Publisher Full Text | Find Related Articles |
| Seissler J
[Future therapeutic options and their indications: transplantation and the possibilities of regenerative therapy for diabetes type 1] [Journal Article]
MMW Fortschr Med 2008 Oct 30; 150(44):50-1.
Full Citation | Find Related Articles |
| Houldsworth J, Petlakh M, Olshen AB, et al.
Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response. [JOURNAL ARTICLE]
Leuk Lymphoma 2008 Nov; 49(11):2170-2180.
Abstract | Full Citation |
  |
